Decreased plasma brain-derived neurotrophic factor and vascular endothelial growth factor concentrations during military training

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Suzuki, Go ^a,b   Tokuno, Shinichi ^c   Nibuya, Masashi ^c   Ishida, Toru ^a   Yamamoto, Tetsuo ^a   Mukai, Yasuo ^a   Mitani, Keiji ^b   Tsumatori, Gentaro ^c   Scott, Daniel ^d   Shimizu, Kunio ^c  

^a Military Medicine Research Unit   (Japan)

^b Japan Self Defense Forces Central Hospital   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MUSCLE ENZYME; VASCULOTROPIN; ANTIDEPRESSANT AGENT; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARMY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; EXERCISE; HUMAN; MALE; MENTAL STRESS; PARTICIPANT OBSERVATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SLEEP DEPRIVATION; SLEEP QUALITY; UPREGULATION; BLOOD; DEPRESSIVE DISORDER; GENETICS; PHYSIOLOGY; PSYCHOLOGY; SOLDIER;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; DOWN-REGULATION; EXERCISE; HUMANS; MILITARY PERSONNEL; SLEEP DEPRIVATION; STRESS, PSYCHOLOGICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896085333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089455     Document Type: Article

References (40)

1. Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-1777.
2. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15, 7539-7547.
3. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, et al. (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26: 115-123. (Pubitemid 39600596)
4. Marano CM, Phatak P, Vemulapalli UR, Sasan A, Nalbandyan MR, et al. (2007) Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry 68: 512-517. (Pubitemid 46663032)
5. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37: 1553-1561. (Pubitemid 28550429)
6. Kim YK, Lee HP, Won SD, Park EY, Lee HY, et al. (2007) Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 31: 78-85.
7. Okuno K, Yoshimura R, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, et al. (2011) Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan. Psychiatry Res 186: 326-332.
8. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, et al. (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57: 1068-1072. (Pubitemid 40613035)
9. Elzinga BM, Molendijk ML, Oude Voshaar RC, Bus BA, Prickaerts J, et al. (2011) The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl) 214: 319-328.
10. Neeper SA, Gómez-Pinilla F, Choi J, Cotman C (1995) Exercise and brain neurotrophins. Nature 373: 109.
11. Zoladz JA, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, et al. (2008) Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol 59 Suppl 7: 119-132.
12. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, et al. (2010) Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol 67: 71-79.
13. Gorgulu Y, Caliyurt O (2009) Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull 80: 158-162.
14. Ibrahim L, Duncan W, Luckenbaugh DA, Yuan P, Machado-Vieira R, et al. (2011) Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Res Bull 86: 129-133.
15. Kotan Z, Sarandöl E, Kirhan E, Ozkaya G, Kirli S (2012) Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. Ther Adv Psychopharmacol 2: 65-74.
16. Takebayashi M, Hashimoto R, Hisaoka K, Tsuchioka M, Kunugi H (2010) Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. J Neural Transm 117: 1119-1122.
17. Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, et al. (2009) VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 33: 146-149.
18. Fornaro M, Rocchi G, Escelsior A, Contini P, Ghio M, et al. (2013) VEGF plasma level variations in duloxetine-treated patients with major depression. J Affect Disord. in press.
19. Sun FY, Guo X (2005) Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79: 180-184.
20. Warner-Schmidt JL, Duman RS (2008) VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol 8: 14-19. (Pubitemid 351168696)
21. Warner-Schmidt JL, Duman RS (2007) VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A 104: 4647-4652. (Pubitemid 47186279)
22. Aitken RC (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62: 989-993.
23. Kamata N, Tanaka K, Morita S, Tagaya H, Kawashima M, et al. (2011) Relationship between autonomic nervous system activity during sleep and fasting glucose in Japanese workers. Ind Health 49: 427-433.
24. Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC (1992) Automatic sleep/wake identification from wrist activity. Sleep 15: 461-469.
25. Sadeh A, Sharkey KM, Carskadon MA (1994) Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep 17: 201-207. (Pubitemid 24174450)
26. Baharav A, Kotagal S, Gibbons V, Rubin BK, Pratt G, et al. (1995) Fluctuations in autonomic nervous activity during sleep displayed by power spectrum analysis of heart rate variability. Neurology 45: 1183-1187.
27. Lee BH, Kim H, Park SH, Kim YK (2007) Decreased plasma BDNF level in depressive patients. J Affect Disord 101: 239-244. (Pubitemid 46879923)
28. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, et al. (2010) Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 13: 535-539.
29. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109: 143-148. (Pubitemid 34258493)
30. Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, et al. (2008) Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Prog Neuropsychopharmacol Biol Psychiatry 32: 679-685. (Pubitemid 351312365)
31. Halmai Z, Dome P, Dobos J, Gonda X, Szekely A, et al. (2013) Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study. J Affect Disord 144: 269-273.
32. Dome P, Halmai Z, Dobos J, Lazary J, Gonda X, et al. (2012) Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression. J Affect Disord 136: 1159-1163.
33. Heine VM, Zareno J, Maslam S, Joëls M, Lucassen PJ (2005) Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci 21: 1304-1314. (Pubitemid 40516629)
34. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, et al. (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23: 10841-10851. (Pubitemid 37499691)
35. Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS (2009) Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology 34: 2459-2468.
36. Chen TC, Hsieh SS (2001) Effects of a 7-day eccentric training period on muscle damage and inflammation. Med Sci Sports Exerc 33: 1732-1738. (Pubitemid 32963876)
37. Lang H, Würzburg U (1982) Creatine kinase, an enzyme of many forms. Clin Chem 28: 1439-1447. (Pubitemid 12090679)
38. Schimke RT (1973) Control of enzyme levels in mammalian tissues. Adv Enzymol Relat Areas Mol Biol 37: 135-187.
39. Tang SW, Chu E, Hui T, Helmeste D, Law C (2008) Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci Lett 431: 62-65.
40. Suzuki T, Ouchi K, Kameyama K, Takahashi M (2009) Development of a sleep monitoring system with wearable vital sensor for home use. BIODEVICES, 326-331. Available: http://www.itc-ltd.co.jp/pdf/BIODEVICES-2009-124.pdf?. Accessed 2013 Oct 7.